Back
 

View:
Mini 
BasicThis view is available after user registration.
 
ShortThis view is available when you buy a license.
 
StandardThis view is available when you buy a license.
 
CompleteThis view is available when you buy a license.
 

Nivolumab 1 / Ipilimumab 3, Melanoma, Malignant, Adjuvant, cycle 1-4

Protocol-ID: 1894 V1.2 (Mini), NIVO1/IPIL3, Melanoma, adj., C1-4

Indication(s)

  • Melanoma, Malignant; ICD-10 C44.-
The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti.

Valid since: 27.01.2023